CINELLI, MARINA
CINELLI, MARINA
MEDICINA INTERNA (attivo dal 01/01/1999 al 31/12/2012)
A Topology-Based Approach for Predicting Toxic Outcomes on Twitter and YouTube
2024 Etta G.; Cinelli M.; Marco N.D.; Avalle M.; Panconesi A.; Quattrociocchi W.
Acetylation and phosphorylation of the carboxy-terminal domain of p53: regulative significance
1998 V.CHIARUGI; M.CINELLI; L.MAGNELLI
Apoptosis induction in 32D cells by IL-3 withdrawal id preceded by a drop in the intracellular calcium level
1993 Magnelli, Lucia; Cinelli, Marina; Turchetti, A.; Chiarugi, Vincenzo
Apoptosis: molecular regulation of cell death and hematologic malignancies.
2002 V.Chiarugi; M.Cinelli; L.Magnelli; P. DELLO SBARBA
bcl-2 overexpression abolishes early calcium waving preceding apoptosis in NIH-3T3 murine fibroblasts
1994 L.Magnelli; M.Cinelli; A.Turchetti; V.Chiarugi
Cell survival and death programmes.
1994 V.CHIARUGI; L.MAGNELLI; A.TURCHETTI; M.CINELLI; S.CAVARI; M.RUGGIERO
Chronic treatment of human fibroblasts cultures with diacyl-glycerol induces down-regulation of p53 functional activity.
1998 L.MAGNELLI; M.CINELLI; V.CHIARUGI
Complex interplay among apoptosis factors: RB, p53, E2F, TGF-beta, cell cycle inhibitors and the bcl2 gene family.
1997 V.CHIARUGI; M.CINELLI; L.MAGNELLI
Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study
2005 Iannone, Florenzo; Matucci-Cerinic, Marco; Falappone, Paola Chiara Francesca; Guiducci, Serena; Cinelli, Marina; Distler, Oliver; Lapadula, Giovanni
Erratum: "The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn) (Clinical and Experimental Rheumatol (2005) vol. 23 (5) (671-677))
2005 F Bandinelli , F Bartoli, E Perfetto, A Del Rosso, A Moggi-Pignone, S Guiducci, M Cinelli, C Fatini, S Generini, A Gabrielli, R Giacomelli, S Maddali Bongi, R Abbate, M Del Rosso, M Matucci Cerinic
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis.
2007 Pignone A; Mori F; Pieri F; Oddo A; Galeota G; Fiori G; Del Rosso A; Perfetto F; Becucci A; Livi R; Tempestini A; Benvenuti C; Gramigna L; Fedi R; Generini S; Minelli M; Cinelli M; Guiducci S; Arcangeli C; Conforti ML; Bernardo P; Cerinic MM
Functional Regulative Pathways for p53, a Protein of Basic Importance for the Integrity of the Cell Genome
1999 V. CHIARUGI; M. CINELLI; L. MAGNELLI; M. RUGGIERO
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.
2004 D'ALESSIO S; G. FIBBI; CINELLI M; GUIDUCCI S; DEL ROSSO A; MARGHERI F; SERRATI S; PUCCI M; KAHALEH B; FAN P; ANNUNZIATO F; COSMI L; LIOTTA F; MATUCCI CERINIC M; DEL ROSSO M
p53: Radiosensitivity and Antiangiogenic Effects
1998 V.CHIARUGI; M.CINELLI; L.MAGNELLI
Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect ts-p53/K562 from apoptosis
1995 L.Magnelli; M.Cinelli; V.Chiarugi
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
2005 S.Guiducci; A.Del Rosso; M.Cinelli; F.Perfetto; R.Livi; A.Rossi; A.Gabrielli; R.Giacomelli; N.Iori; G.Fibbi; M.Del Rosso; M. Matucci Cerinic
Redundant down-regulation pathways for p53.
1998 M.CINELLI; L.MAGNELLI; V.CHIARUGI
Role of p53 mutations in the radiosensitivity status of tumor cells
1998 V.CHIARUGI; L.MAGNELLI; M.CINELLI
Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
2006 SERRATI S; CINELLI M; MARGHERI F; GUIDUCCI S; DEL ROSSO A; PUCCI M; G. FIBBI; BAZZICHI L; BOMBARDIERI S; MATUCCI CERINIC M; DEL ROSSO M
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.
2005 B.GIUSTI; S.SERRATI'; F.MARGHERI; L.PAPUCCI; L.ROSSI; F.POGGI; A.MAGI; A.DEL ROSSO; M.CINELLI; S.GUIDUCCI; B.KAHALEH; M.MATUCCI CERINIC; R.ABBATE; G. FIBBI; M.DEL ROSSO